Aerovance

About:

Aerovance is a biotech company focused on developing and commercializing medicines for respiratory and allergic diseases.

Website: http://www.aerovance.com

Top Investors: Apax Partners, Silicon Valley Bank, Alta Partners, Clarus Ventures, NGN Capital

Description:

Aerovance is a privately held biopharmaceutical company exclusively focused on developing and commercializing breakthrough medicines for respiratory and allergic diseases. The company maintains a solid intellectual property position with its strong portfolio of novel therapeutic candidates now in clinical development and several pre-clinical programs. The two lead products are human recombinant proteins: Aerovantâ„¢, an IL-4 and -13 receptor antagonist which is in Phase IIa studies for asthma and Aerodermâ„¢, a PEGylated IL-4 and IL-13 receptor antagonist in pre-clinical studies for eczema.